Comprehensive Cell Solutions

Comprehensive Cell Solutions (CCS) is a leading U.S.-based CDMO specializing in process development, sourcing, GMP manufacturing, cryopreservation, analytical testing, fill/finish operations, supply chain logistics, regulatory support, and clinical trial management for cell-, gene-, and regenerative-medicine developers. It leverages decades of expertise from its parent organization—the New York Blood Center Enterprises—and operates one of the world’s largest cord blood banks. CCS serves academic institutions to large pharma with “draw-to-thaw” solutions across multiple U.S. sites. The company does not develop its own therapeutics but provides critical infrastructure enabling others’ R&D from preclinical through commercial stages.